FULCRUM THERAPEUTICS, INC. Shares Issued
FULCRUM THERAPEUTICS, INC. (FULC) had Shares Issued of 76.29 million shares as of 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-09-02
- 2026-06-30: Common Stock, Shares, Issued 76.29M shares.
- 2026-03-31: Common Stock, Shares, Issued 66.61M shares.
- 2025-12-31: Common Stock, Shares, Issued 66.58M shares.
- 2025-09-30: Common Stock, Shares, Issued 54.11M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 76.29M shares S-4 · filed 2026-09-02 |
| 2026-03-31 | 66.61M shares 10-Q · filed 2026-04-27 |
| 2025-12-31 | 66.58M shares S-4 · filed 2026-09-02 |
| 2025-09-30 | 54.11M shares 10-Q · filed 2025-10-29 |
| 2025-06-30 | 54.09M shares 10-Q · filed 2025-07-29 |
| 2025-03-31 | 53.98M shares 10-Q · filed 2025-05-01 |
| 2024-12-31 | 53.97M shares S-4 · filed 2026-09-02 |
| 2024-09-30 | 53.94M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 62.25M shares 10-Q · filed 2024-07-31 |
| 2024-03-31 | 62.14M shares 10-Q · filed 2024-05-13 |
| 2023-12-31 | 61.92M shares 10-K · filed 2025-02-25 |
| 2023-09-30 | 61.82M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 61.82M shares 10-Q · filed 2023-08-03 |
| 2023-03-31 | 61.76M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 52.10M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 52.05M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 41.01M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 40.68M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 40.64M shares 10-K/A · filed 2023-06-26 |
| 2021-09-30 | 40.55M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 32.71M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 32.68M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 28.07M shares 10-K/A · filed 2023-06-26 |
| 2020-09-30 | 27.46M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 27.45M shares 10-Q · filed 2020-08-11 |
| 2020-03-31 | 23.36M shares 10-Q · filed 2020-05-13 |
| 2019-12-31 | 23.34M shares 10-K/A · filed 2023-06-23 |
| 2019-09-30 | 23.34M shares 10-Q · filed 2019-11-14 |
| 2019-06-30 | 2.77M shares 10-Q · filed 2019-08-26 |
| 2018-12-31 | 2.79M shares 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |